Three tools for successful risk-based pharma negotiations
Biopharmaceutical manufacturers’ at-risk day is coming. Here’s how to prepare.
View ArticleTop ways you can impact drug spending
How at-risk negotiations with pharmaceutical manufacturers and medication adherence programs improve both sides of the healthcare value equation: patient outcomes and costs.
View ArticleThree ways to maximize value in cancer treatment
Advancements in treatment show cancer trending towards a chronic condition. Align your cancer chronic care management team now. Here’s how. Advancements in treatment show cancer trending towards a...
View Article
More Pages to Explore .....
